- Report
- March 2024
- 199 Pages
Global
From €3232EUR$3,374USD£2,752GBP
€3591EUR$3,749USD£3,058GBP
- Report
- May 2024
- 186 Pages
Global
From €3232EUR$3,374USD£2,752GBP
€3591EUR$3,749USD£3,058GBP
- Report
- January 2024
- 150 Pages
Global
From €5699EUR$5,950USD£4,853GBP
- Report
- February 2024
- 175 Pages
Global
From €4789EUR$5,000USD£4,078GBP
- Report
- October 2023
- 150 Pages
Global
From €2394EUR$2,499USD£2,038GBP
- Report
- May 2024
- 194 Pages
Global
From €4741EUR$4,950USD£4,037GBP
- Report
- February 2024
- 188 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2873EUR$3,000USD£2,447GBP
- Report
- April 2024
- 152 Pages
Global
From €3783EUR$3,950USD£3,222GBP
- Report
- June 2023
- 200 Pages
Global
From €7183EUR$7,500USD£6,117GBP
- Report
- October 2023
- 190 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- April 2024
- 115 Pages
Global
From €4310EUR$4,500USD£3,670GBP
- Report
- February 2024
- 175 Pages
Global
From €4789EUR$5,000USD£4,078GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1916EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1916EUR$2,000USD£1,631GBP
- Report
- February 2024
- 110 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- March 2024
- 200 Pages
Global
From €3975EUR$4,150USD£3,385GBP
- Report
- April 2022
- 191 Pages
Global
From €3051EUR$3,185USD£2,598GBP
€4358EUR$4,550USD£3,711GBP
- Report
- April 2023
- 115 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- April 2023
- 240 Pages
Global
From €3352EUR$3,500USD£2,855GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more